Susquehanna International Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-112,500
| Closed | -$108K | – | 13445 |
|
|
2023
Q2 | $108K | Buy |
112,500
+38,700
| +52% | +$38.2K | ﹤0.01% | 10901 |
|
|
2023
Q1 | $55.4K | Buy |
73,800
+27,600
| +60% | +$20.1K | ﹤0.01% | 11658 |
|
|
2022
Q4 | $17.1K | Sell |
46,200
-137,000
| -75% | -$57.8K | ﹤0.01% | 11812 |
|
|
2022
Q3 | $79K | Buy |
183,200
+147,500
| +413% | +$145K | ﹤0.01% | 11902 |
|
|
2022
Q2 | $28K | Buy |
35,700
+18,700
| +110% | +$16.5K | ﹤0.01% | 12260 |
|
|
2022
Q1 | $22K | Sell |
17,000
-96,200
| -85% | -$88.6K | ﹤0.01% | 12603 |
|
|
2021
Q4 | $144K | Sell |
113,200
-28,800
| -20% | -$51.5K | ﹤0.01% | 11842 |
|
|
2021
Q3 | $310K | Buy |
142,000
+17,300
| +14% | +$47.3K | ﹤0.01% | 10530 |
|
|
2021
Q2 | $468K | Sell |
124,700
-15,900
| -11% | -$55.3K | ﹤0.01% | 9747 |
|
|
2021
Q1 | $458K | Buy |
140,600
+200
| +0.1% | +$717 | ﹤0.01% | 9691 |
|
|
2020
Q4 | $479K | Buy |
140,400
+114,700
| +446% | +$472K | ﹤0.01% | 8385 |
|
|
2020
Q3 | $105K | Buy |
25,700
+8,100
| +46% | +$30.8K | ﹤0.01% | 9894 |
|
|
2020
Q2 | $59K | Sell |
17,600
-11,500
| -40% | -$33.5K | ﹤0.01% | 9708 |
|
|
2020
Q1 | $68K | Sell |
29,100
-181,100
| -86% | -$496K | ﹤0.01% | 9534 |
|
|
2019
Q4 | $765K | Sell |
210,200
-97,000
| -32% | -$784K | ﹤0.01% | 6060 |
|
|
2019
Q3 | $2.55M | Buy |
307,200
+79,900
| +35% | +$646K | ﹤0.01% | 3765 |
|
|
2019
Q2 | $1.96M | Buy |
227,300
+133,500
| +142% | +$1.19M | ﹤0.01% | 4207 |
|
|
2019
Q1 | $1M | Buy |
93,800
+18,000
| +24% | +$193K | ﹤0.01% | 5041 |
|
|
2018
Q4 | $663K | Sell |
75,800
-76,200
| -50% | -$971K | ﹤0.01% | 5475 |
|
|
2018
Q3 | $2.55M | Buy |
152,000
+54,500
| +56% | +$1.18M | ﹤0.01% | 3619 |
|
|
2018
Q2 | $2.04M | Sell |
97,500
-35,700
| -27% | -$661K | ﹤0.01% | 3981 |
|
|
2018
Q1 | $2.14M | Buy |
133,200
+56,000
| +73% | +$1.11M | ﹤0.01% | 3789 |
|
|
2017
Q4 | $1.46M | Sell |
77,200
-12,500
| -14% | -$226K | ﹤0.01% | 4511 |
|
|
2017
Q3 | $1.26M | Buy |
89,700
+73,400
| +450% | +$664K | ﹤0.01% | 4838 |
|
|
2017
Q2 | $121K | Buy |
16,300
+900
| +6% | +$5.88K | ﹤0.01% | 8599 |
|
|
2017
Q1 | $100K | Buy |
+15,400
| New | +$86.1K | ﹤0.01% | 8393 |
|
|
2016
Q4 | – | Sell |
-14,800
| Closed | -$69K | – | 10335 |
|
|
2016
Q3 | $69K | Buy |
+14,800
| New | +$87.7K | ﹤0.01% | 8052 |
|
|
2015
Q3 | – | Sell |
-29,400
| Closed | -$201K | – | 10360 |
|
|
2015
Q2 | $201K | Sell |
29,400
-101,200
| -77% | -$643K | ﹤0.01% | 9285 |
|
|
2015
Q1 | $793K | Buy |
130,600
+33,600
| +35% | +$224K | ﹤0.01% | 6221 |
|
|
2014
Q4 | $672K | Sell |
97,000
-12,300
| -11% | -$90.4K | ﹤0.01% | 6650 |
|
|
2014
Q3 | $890K | Sell |
109,300
-71,700
| -40% | -$561K | ﹤0.01% | 6150 |
|
|
2014
Q2 | $1.47M | Sell |
181,000
-32,000
| -15% | -$243K | ﹤0.01% | 5269 |
|
|
2014
Q1 | $1.67M | Buy |
213,000
+129,200
| +154% | +$1.09M | ﹤0.01% | 4628 |
|
|
2013
Q4 | $742K | Sell |
83,800
-141,500
| -63% | -$1.26M | ﹤0.01% | 6031 |
|
|
2013
Q3 | $1.89M | Sell |
225,300
-102,700
| -31% | -$832K | ﹤0.01% | 4181 |
|
|
2013
Q2 | $2.45M | Buy |
+328,000
| New | +$2.52M | ﹤0.01% | 3602 |
|
Susquehanna International Group's SPPI Position: Q3 2023 in Review
Susquehanna International Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 243,555 shares — an estimated $234K sold.
Susquehanna International Group first reported a position in SPPI in Q2 2013 and held it in 35 quarters. The position peaked at $2.61M in Q4 2013. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Susquehanna International Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 243,555 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $234K.
- Susquehanna International Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Susquehanna International Group's Spectrum Pharmaceuticals Inc position peaked at $2.61M in Q4 2013.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.